Dostarlimab | All | Licensing, EU CTD Dossiers, Formulation Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Dostarlimab
FDF Dossiers

Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Contact Supplier

Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Contact Supplier

Moehs Group, a reference company in the production of pharmaceutical active ingredients.

Contact Supplier

pharmacompass-2-m-2025-10-20

Dostarlimab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

129 Drugs in Development

129 Drugs in Development

FINISHED DOSAGE FORMULATIONS

9 FDF Dossiers, 2 FDA Orange Book, 2 Europe, 1 Canada, 4 Australia

9 FDF Dossiers
2 FDA Orange Book
2 Europe
1 Canada
4 Australia

DIGITAL CONTENT

1 Stock Recap #PipelineProspector, 50 News #PharmaBuzz

1 Stock Recap #PipelineProspector
50 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Annual Reports

1 US Medicaid Prescriptions
4 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

9 All

01 9GSK

filter Dosage Reset all filters

9 All

01 1Concentrate For Infusion Solution

02 1Concentrate For Solution For Infusion

03 2INJECTABLE;INJECTION

04 1SOLUTION

05 4Blank

filter Regulatory Info Reset all filters

9 All

01 1Approved

02 1Authorized

03 1Prescription

04 6Blank

filter Brand Name Reset all filters

9 All

01 3JEMPERLI

02 6Jemperli

filter Country Reset all filters

9 All

01 4Australia

02 1Canada

03 1Spain

04 1Sweden

05 2USA

List of Suppliers

Product Main Page

01

GSK

ISPE Annual Meeting

Not Confirmed

GSK

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

DOSTARLIMAB-GXLY

Brand Name : JEMPERLI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 500MG/10ML

Packaging :

Approval Date :

Application Number : 761174

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GSK

ISPE Annual Meeting

Not Confirmed

GSK

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

DOSTARLIMAB-GXLY

Brand Name : JEMPERLI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 500MG/10ML

Packaging :

Approval Date :

Application Number : 761223

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GSK

ISPE Annual Meeting

Not Confirmed

GSK

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Dostarlimab

Brand Name : Jemperli

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 500mg

Packaging :

Approval Date : 21/04/2021

Application Number : 20200310000019

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GSK

ISPE Annual Meeting

Not Confirmed

GSK

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DOSTARLIMAB

Brand Name : JEMPERLI

Dosage Form : SOLUTION

Dosage Strength : 50MG/ML

Packaging :

Approval Date :

Application Number : 2523434

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GSK

ISPE Annual Meeting

Not Confirmed

GSK

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Dostarlimab

Brand Name : Jemperli

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GSK

ISPE Annual Meeting

Not Confirmed

GSK

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Dostarlimab

Brand Name : Jemperli

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

GSK

ISPE Annual Meeting

Not Confirmed

GSK

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Dostarlimab

Brand Name : Jemperli

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

GSK

ISPE Annual Meeting

Not Confirmed

GSK

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Dostarlimab

Brand Name : Jemperli

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

GSK

ISPE Annual Meeting

Not Confirmed

GSK

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Dostarlimab

Brand Name : Jemperli

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 500MG

Packaging :

Approval Date : 2021-05-25

Application Number : 1211538001

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!